Inari Medical (NASDAQ:NARI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by Robert W. Baird in a research note issued to investors on Tuesday,Benzinga reports. They presently have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback